Monday, May 1, 2017

Fresenius pushes further into generics

German firm to acquire U.S. generics maker Akorn and Merck KGaA’s biosimilars business

TOC Graphic



via Chemical & Engineering News: Biological SCENE http://ift.tt/2qnL0yu
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)